Skip to main content

Featured

Hands-on approach to mental illness

With the aim of combatting the fear and misconceptions surrounding mental illness, Castle Peak Hospital’s Mind Space museum enables visitors to experience hallucinations, similar to the sensory experiences mentally ill patients encounter, by way of rooms that utilise virtual reality (VR) technology.   A group of secondary students recently embarked on a journey through Mind Space after registering and receiving patient wristbands. This unique mental health experience museum provided them with a comprehensive understanding of the development of psychiatric services in Hong Kong.   Displays in the museum showcase intriguing relics, including the evolution of restraints and handwritten patient records. Additionally, the students were given the opportunity to explore a mock protection room designed to provide a calming environment for patients.   Furthermore, students could learn about the scientific aspects behind the causes of mental illness at the Brain Tour zone. One of the

Vaccine protection under scrutiny

Secretary for Food & Health Prof Sophia Chan said experts of the Joint Scientific Committee under the Centre for Health Protection will monitor the situation of new COVID-19 variants and review the data on the protection of various vaccines against such variants.   Speaking to the media after attending a radio programme today, Prof Chan noted that the committee has given information about the protection of different vaccines against the new variants.   She said: “According to the experts, the BioNtech vaccine is able to protect against some of the variants of concern. For the Sinovac vaccine, they are still waiting for further information from Sinovac.   “The experts will continue to monitor the situation and review any data provided to the Department of Health.”   For the vaccine produced by AstraZeneca, which the Government has signed an advance purchase agreement with, Prof Chan said the Government is aware of the news reports concerning the vaccine in different countries.   “We also notice there is news from the World Health Organization and also some countries most recently said that all the adverse effects are not related to or do not have a direct relationship with the vaccination of the AstraZeneca vaccine.   “We will continue to monitor the situation and the Department of Health has asked the manufacturer for further information.”   She explained that regarding the procedure, the manufacturer must first apply for approval for use in Hong Kong and the Advisory Panel on COVID-19 Vaccines will review the data before it recommends it for authorisation by the Government.   Such a process has not yet started, Prof Chan added.
http://dlvr.it/Rw1Gcv

Popular Posts